Quotient Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$366K Hold
4,274
0.25% 108
2017
Q2
$352K Sell
4,274
-600
-12% -$49K 0.25% 105
2017
Q1
$410K Sell
4,874
-100
-2% -$8.01K 0.25% 122
2016
Q4
$366K Buy
4,974
+2,300
+86% +$171K 0.23% 125
2016
Q3
$215K Sell
2,674
-1,918
-42% -$154K 0.14% 159
2016
Q2
$362K Sell
4,592
-15,114
-77% -$1.14M 0.17% 151
2016
Q1
$1.42M Buy
19,706
+8,466
+75% +$641K 0.52% 70
2015
Q4
$947K Buy
+11,240
New +$933K 0.36% 84

Other funds holding LLY

Quotient Investors's LLY Position: Q3 2017 in Review

Quotient Investors held its Eli Lilly (LLY) position steady in Q3 2017 at 4,274 shares worth $366K. The position accounts for 0.25% of the portfolio, ranked #108.

Quotient Investors first reported a position in LLY in Q4 2015 and has held it in 8 quarters since. The position peaked at $1.42M in Q1 2016. 1,229 funds tracked by Wall St. Rank hold LLY as of Q3 2017.

  • Quotient Investors held 4,274 shares of Eli Lilly worth $366K as of Q3 2017.
  • Quotient Investors left its Eli Lilly share count unchanged in Q3 2017.
  • Eli Lilly made up 0.25% of Quotient Investors's portfolio in Q3 2017, its #108 holding.
  • Quotient Investors first reported a position in Eli Lilly in Q4 2015 and has held it in 8 quarters since.
  • Quotient Investors's Eli Lilly position peaked at $1.42M in Q1 2016.
  • 1,229 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.